Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.22.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2021
Dec. 31, 2020
Current assets:    
Cash and cash equivalents $ 24,983 $ 25,218
Marketable securities, current 118,061 68,667
Prepaid expenses 3,917 4,140
Accounts receivable, related party 0 234
Other current assets 1,254 1,125
Total current assets 148,215 99,384
Marketable securities, non-current 8,986 0
Operating lease right-of-use assets 8,608 11,104
Property and equipment, net 19,309 22,254
Other assets 7,244 7,135
Total assets 192,362 139,877
Current liabilities:    
Accounts payable 1,612 2,350
Accrued liabilities 9,515 12,575
Deferred revenue, current 32,937 14,014
Deferred revenue, current, related party 0 789
Other current liabilities, related party 0 5,614
Other current liabilities 2,606 2,211
Total current liabilities 46,670 37,553
Deferred revenue, long-term 33,350 4,538
Deferred revenue, long-term, related party 0 3,106
Long-term debt, net of current portion 35,491 14,926
Operating lease liabilities 9,564 12,213
Other liabilities, related party 0 6,711
Other liabilities 1,625 1,490
Total liabilities 126,700 80,537
Commitments and contingencies (Note 10) 0 0
Stockholders’ equity    
Preferred stock, $0.001 par value: Authorized: 2,000,000 shares at December 31, 2020 and December?31, 2019; issued and outstanding: 250 shares at December 31, 2020 and December?31, 2019 0 0
Authorized: 150,000,000 shares at December 31, 2021 and December 31, 2020; issued and outstanding: 56,305,049 shares at December 31, 2021 and 49,984,333 shares at December 31, 2020 56 50
Additional paid-in capital 417,704 328,314
Accumulated other comprehensive income, (loss) (48) 17
Accumulated deficit (352,050) (269,041)
Total stockholders’ equity 65,662 59,340
Total liabilities and stockholders’ equity $ 192,362 $ 139,877